Navigation Links
HIV/AIDS Vaccine Tests on Animals shows Promise

An HIV/AIDS vaccine has proved to be efficient on animals according to researchers at the University of Western Ontario.//

"Perhaps we can cure HIV infection. This is our hope," said Dr. Young Kang at the University of Western Ontario. Clinical trials of the vaccine are expected soon with almost $5i million to be invested by Curocom Co., a company in Korea, into this new medical revelation.

Dr. Yong Kang said, "We have to be careful because we have done the animal, the immune response studies. But that doesn't mean we can repeat exactly the same kind of results in humans."

"We expect that the initial tests will clear the way for this vaccine to be used therapeutically within three years to treat patients suffering from low-level HIV infection," stated Dr. Young Kang who hopes to curb the spread of the HIV virus with this new medical discovery.

He said, "I hope that this research will work for the treatment as well as the prevention of HIV infection.

But we really have to wait until we finish up to the Phase 2 human trials before we can tell whether or not this is going to work or not."

Researchers are currently seeking the U.S. Food and Drug Administration's permission of starting the test on humans.
NLA
'"/>




Page: 1

Related medicine news :

1. Optimum Timing for HIV/AIDS Prognosis
2. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
3. Testing For HIV/AIDS Compulsory For New Military Recruits
4. HIV/AIDS - May push Back the Tide of Progress in India
5. Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness
6. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
7. Relief for HIV/AIDS patients: ART therapy now available in India
8. Conditions Of The HIV/AIDS Patients In The Mizo Society
9. Liberia in safe hands with respect to HIV/AIDS
10. Men queue up for Circumcision In Swaziland To Prevent HIV/AIDS
11. HIV/AIDS Throws Family Relationships Out Of Gear In Uganda
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona Arizona's ... brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and wellness ... to the store is just one more way Shamangelic Healing supports people’s quest ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... awareness and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics ... 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... infants born with severe congenital diaphragmatic hernia have better survival rates if surgery ... diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent ... Gyrociser, an exercise invention which aids in proper muscle development. , "The Gym ... and Creative Director of World Patent Marketing. "Globalization has threatened the future growth ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... , April 28, 2016   Acsis , a ... that leading IT market research and advisory firm IDC ... the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software ... report provides an assessment of the capabilities and business ... trace software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... Schweiz, April 27, 2016 ... CEO Forums in Zürich gab Strekin AG ... Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens von ... bekannt. Für die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe ... angeworben. STR001 wird während der Operation direkt ...
Breaking Medicine Technology: